Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Tokai Univ. Initiates Drug Discovery Project
April 29, 2002
- Animal Study Contracts Increasing: Huntingdon Life Sciences
April 29, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 29, 2002
- BUSINESS NEWS IN BRIEF
April 29, 2002
- Tokyo Katei Yakko Proposes New Distribution for Home Remedies
April 29, 2002
- WEBSITE NEWS
April 29, 2002
- LIFE Corporation to Expand Health Food Product Line
April 29, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
April 29, 2002
- NPO to Be Inaugurated to Promote Self-medication
April 29, 2002
- Kusuri Proverbs Reveal Japanese Spirit (8)
April 29, 2002
- Drug Terashima: Sales Up to \37,883 Mil.
April 29, 2002
- 8 NCEs Including Infliximab Included in NHI Price List
April 29, 2002
- Showa Denko Develops Anesthetic Waste Gas Disposal System
April 29, 2002
- Applicants' Sales Forecasts for New Drugs Announced by Korosho
April 29, 2002
- MEDICAL DEVICE NEWS IN BRIEF
April 29, 2002
- Korosho Invites Opinions on Its Vision from Industry
April 29, 2002
- Becton Dickinson Proposes Safe, Efficient Lab Testing Centers
April 29, 2002
- BULLETIN
April 29, 2002
- Eli Lilly Asked to Distribute Dear-Doctor Letter on Zyprexa
April 29, 2002
- Sysmex: New Blood Cell Analyzer XT-2000i
April 29, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…